Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yi Bin Pan, Yasuko Maeda, Ana Wilson, Rob Glynne-Jones & Carolynne J. Vaizey. (2018) Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review. Acta Oncologica 57:11, pages 1427-1437.
Read now
Read now
Kurian Joseph, Heather Warkentin, Karen Mulder & Corinne Doll. (2018) Minimizing hematological toxicity in the management of anal cancer patients. Expert Review of Quality of Life in Cancer Care 3:1, pages 27-33.
Read now
Read now
Heidi S. Rønde, Leonard Wee, John Pløen & Ane L. Appelt. (2017) Feasibility of preference-driven radiotherapy dose treatment planning to support shared decision making in anal cancer. Acta Oncologica 56:10, pages 1277-1285.
Read now
Read now
Pierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Mario Morino, Gianmauro Numico & Umberto Ricardi. (2017) Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective. Expert Review of Anticancer Therapy 17:4, pages 335-345.
Read now
Read now
Jon Espen Dale, Sigrun Sebjørnsen, Sabine Leh, Cornelia Rösler, Stein Aaserud, Bjørn Møller, Øystein Fluge, Christian Erichsen, Saied Nadipour, Hartwig Kørner, Frank Pfeffer & Olav Dahl. (2017) Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica 56:1, pages 81-87.
Read now
Read now
Articles from other publishers (20)
Poolakkad S. Satheeshkumar, Roberto Pili, Joel B. Epstein, Sudheer B. Kurunthatil Thazhe, Rhine Sukumar & Minu Ponnamma Mohan. (2023) Characteristics and predictors associated with cancer-related fatigue among solid and liquid tumors. Journal of Cancer Research and Clinical Oncology 149:15, pages 13875-13888.
Crossref
Crossref
C. Fiandra, S. Rosati, F. Arcadipane, N. Dinapoli, M. Fato, P. Franco, E. Gallio, D. Scaffidi Gennarino, P. Silvetti, S. Zara, U. Ricardi & G. Balestra. (2023) Active bone marrow segmentation based on computed tomography imaging in anal cancer patients: A machine-learning-based proof of concept. Physica Medica 113, pages 102657.
Crossref
Crossref
Cathy Eng, Kristen K. Ciombor, May Cho, Jennifer A. Dorth, Lakshmi N. Rajdev, David P. Horowitz, Marc J. Gollub, Alexandre A. Jácome, Natalie A. Lockney, Roberta L. Muldoon, Mary Kay Washington, Brittany A. O'Brian, Amala Benny, Cody M. Lebeck Lee, Al B. BensonIIIIII, Karyn A. Goodman & Van Karlyle Morris. (2022) Anal Cancer: Emerging Standards in a Rare Disease. Journal of Clinical Oncology 40:24, pages 2774-2788.
Crossref
Crossref
Nicholas Damico, Joshua Meyer, Prajnan Das, James Murphy, Eric Miller, Bridget Koontz, William Hall, Mary McBride, Gisele Pereira, Paul Catalano, A. Bapsi Chakravarthy, Peter J. O'Dwyer & Jennifer Dorth. (2022) ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT. Practical Radiation Oncology 12:4, pages 335-347.
Crossref
Crossref
M.P. Nilsson, A. Gunnlaugsson, A. Johnsson & J. Scherman. (2022) Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer. Clinical Oncology 34:1, pages e35-e44.
Crossref
Crossref
Dandan Wang, Yueju Yin, Qichao Zhou, Zirong Li, Xingmin Ma, Yong Yin, Baosheng Li, Tong Bai, Dapeng Li & Jian Zhu. (2021) Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation. Medical Physics 49:1, pages 756-767.
Crossref
Crossref
Poolakkad S. Satheeshkumar, Mohammed El-Dallal & Minu P. Mohan. (2021) Feature selection and predicting chemotherapy-induced ulcerative mucositis using machine learning methods. International Journal of Medical Informatics 154, pages 104563.
Crossref
Crossref
Jahan J. Mohiuddin, Krishan R. Jethwa, Nikhil Grandhi, William G. Breen, Xingmei Wang, Akbar Anvari, Hui Lin, Harigopal Sandhyavenu, Abigail Doucette, John P. Plastaras, William G. Rule, James M. Metz, Kenneth W. Merrell, Terence T. Sio, Jonathan B. Ashman, Michael G. Haddock, Edgar Ben-Josef, Christopher L. Hallemeier & Andrzej P. Wojcieszynski. (2021) Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus. Advances in Radiation Oncology 6:5, pages 100744.
Crossref
Crossref
Eric Miller & Jose Bazan. (2021) De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus. Cancers 13:9, pages 2099.
Crossref
Crossref
L. Kuntz & G. Noel. (2021) Irradiation pelvienne et toxicité hématopoïétique : revue de la littérature. Cancer/Radiothérapie 25:1, pages 77-91.
Crossref
Crossref
H. R. Wardill, S. T. Sonis, N. M. A. Blijlevens, Y. Z. A. Van Sebille, M. A. Ciorba, E. A. H. Loeffen, K. K. F. Cheng, P. Bossi, L. Porcello, D. A. Castillo, S. Elad & J. M. Bowen. (2020) Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Supportive Care in Cancer 28:11, pages 5059-5073.
Crossref
Crossref
Samanta Rosati, Pierfrancesco Franco, Christian Fiandra, Francesca Arcadipane, Patrick Silvetti, Elena Gallio, Jovana Panic, Umberto Ricardi & Gabriella Balestra. (2020) Comparison of different classifiers to recognize active bone marrow from CT images. Comparison of different classifiers to recognize active bone marrow from CT images.
Philippe Lambin, Relinde I.Y. Lieverse, Franziska Eckert, Damiënne Marcus, Cary Oberije, Alexander M.A. van der Wiel, Chandan Guha, Ludwig J. Dubois & Joseph O. Deasy. (2020) Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. Seminars in Radiation Oncology 30:2, pages 187-193.
Crossref
Crossref
Ane L. Appelt, Ellen M. Kerkhof, Lars Nyvang, Ernst C. Harderwijk, Natalie L. Abbott, Mark Teo, Femke P. Peters, Camilla J.S. Kronborg, Karen-Lise G. Spindler, David Sebag-Montefiore & Corrie A.M. Marijnen. (2019) Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study. Technical Innovations & Patient Support in Radiation Oncology 11, pages 14-21.
Crossref
Crossref
S. Rosati, G. Balestra, P. Franco, C. Fiandra, F. Arcadipane, P. Silvetti, U. Ricardi & E. Gallio. (2018) Radiomics for Identification of Active Bone Marrow from CT: An Exploratory Study. Radiomics for Identification of Active Bone Marrow from CT: An Exploratory Study.
M. Ng, H. Ho, J. Skelton, M. Guerrieri, M. Guiney, M. Chao, D. Blakey, C. Macleod, H. Amor, B. Subramanian & L. Melven. (2018) Intensity-modulated Radiotherapy for Anal Cancer: Dose–Volume Relationship of Acute Gastrointestinal Toxicity and Disease Outcomes. Clinical Oncology 30:10, pages 634-641.
Crossref
Crossref
Marija Radojević-Živković, Vesna Karapandžić-Plesinac, Aleksandar Tomašević, Neda Milosavljević & Marko Folić. (2018) Acute radiation toxicity during and after concurrent chemoradiotherapy in patients with localy advanced cervical cancer. Racionalna terapija 10:2, pages 43-51.
Crossref
Crossref
Nan Li, Xue Liu, Fushan Zhai, Bing Liu, Xiaohui Cao, Shuyan Li, Minxian Zhang & Ming Liu. (2017) Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy. Oncotarget 8:54, pages 92904-92913.
Crossref
Crossref
Karyn A. Goodman, Diana Julie, Andrea Cercek, Lajhem Cambridge, Kaitlin M. Woo, Zhigang Zhang, Abraham J. Wu, Diane L. Reidy, Neil H. Segal, Zsofia K. Stadler & Leonard B. Saltz. (2017) Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer. International Journal of Radiation Oncology*Biology*Physics 98:5, pages 1087-1095.
Crossref
Crossref
Ethan B. Ludmir, Lisa A. Kachnic & Brian G. Czito. (2017) Evolution and Management of Treatment-Related Toxicity in Anal Cancer. Surgical Oncology Clinics of North America 26:1, pages 91-113.
Crossref
Crossref